Maravai Lifesciences Holdings, Inc. Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 143.14M284.10M799.24M883.00M288.94M259.19M
Cost of Revenue 66.85M79.65M140.56M168.96M148.74M150.88M
Gross Profit 76.29M204.45M658.68M714.04M140.20M108.31M
Operating items
Research & Development 3.63M9.30M15.22M18.37M17.28M19.22M
Selling, General & Administrative 48.35M94.25M100.06M129.26M151.39M161.77M
Restructuring Costs 6.47M-1.21M
Other Operating Expenses 67.17M60.65M11.25M161.16M145.46M315.02M
Operating Expenses 119.15M164.20M244.59M308.79M320.59M494.80M
Operating Income 23.99M119.90M554.64M574.22M-31.65M-235.62M
EBIT 23.99M119.90M554.64M574.22M-31.65M-235.62M
Non-operating items
Interest & Investment Income 2.34M27.73M27.40M
Other Non Operating Income 0.12M-7.59M0.28M-0.36M-1.34M-3.19M
Non Operating Income 0.12M0.13M0.28M-0.36M-1.34M-2.34M
Net income details
EBT -5.85M81.70M530.76M551.47M617.74M-261.48M
Tax Provisions -0.65M2.88M61.52M60.81M756.11M-1.86M
Profit After Tax -5.20M88.97M469.25M490.66M-138.38M-259.62M
Income from Non-Controlling Interests -0.73M-10.16M287.21M270.46M-19.35M-114.78M
Income from Continuing Operations -5.20M78.82M469.25M490.66M-138.38M-259.62M
Consolidated Net Income -5.20M78.82M469.25M490.66M-138.38M-259.62M
Income towards Parent Company -5.20M78.82M469.25M490.66M-138.38M-259.62M
Net Income towards Common Stockholders -5.20M78.82M469.25M490.66M-138.38M-259.62M
Additional items
EPS (Basic) -0.00M0.00M0.00M0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M0.00M0.00M0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 257.84M257.84M255.16M250.88M251.40M252.53M
Shares Outstanding (Diluted Average) 253.92M28.91M257.80M255.32M131.92M137.91M
EBITDA 23.99M119.90M554.64M574.22M-31.65M-235.62M
Tax Rate 11.14%3.53%11.59%11.03%0.71%